328 related articles for article (PubMed ID: 25900293)
1. A novel tau mutation, p.K317N, causes globular glial tauopathy.
Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
[TBL] [Abstract][Full Text] [Related]
2. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
4. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.
Erro ME; Zelaya MV; Mendioroz M; Larumbe R; Ortega-Cubero S; Lanciego JL; Lladó A; Cabada T; Tuñón T; García-Bragado F; Luquin MR; Pastor P; Ferrer I
J Neurol; 2019 Oct; 266(10):2396-2405. PubMed ID: 31190169
[TBL] [Abstract][Full Text] [Related]
5. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
6. Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions.
Štrafela P; Pleško J; Magdič J; Koritnik B; Zupan A; Glavač D; Bresjanac M; Popović M
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):550-562. PubMed ID: 29215752
[TBL] [Abstract][Full Text] [Related]
7. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
8. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
[TBL] [Abstract][Full Text] [Related]
9. Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.
Kovacs GG; Kwong LK; Grossman M; Irwin DJ; Lee EB; Robinson JL; Suh E; Van Deerlin VM; Lee VM; Trojanowski JQ
Brain Pathol; 2018 Mar; 28(2):274-283. PubMed ID: 28019685
[TBL] [Abstract][Full Text] [Related]
10. Novel tau filament fold in corticobasal degeneration.
Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; Murayama S; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2020 Apr; 580(7802):283-287. PubMed ID: 32050258
[TBL] [Abstract][Full Text] [Related]
11. A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.
Tacik P; DeTure M; Hinkle KM; Lin WL; Sanchez-Contreras M; Carlomagno Y; Pedraza O; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
J Neuropathol Exp Neurol; 2015 Nov; 74(11):1042-52. PubMed ID: 26426266
[TBL] [Abstract][Full Text] [Related]
12. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features.
Rossi G; Bastone A; Piccoli E; Morbin M; Mazzoleni G; Fugnanesi V; Beeg M; Del Favero E; Cantù L; Motta S; Salsano E; Pareyson D; Erbetta A; Elia AE; Del Sorbo F; Silani V; Morelli C; Salmona M; Tagliavini F
Neurobiol Aging; 2014 Feb; 35(2):408-17. PubMed ID: 24018212
[TBL] [Abstract][Full Text] [Related]
13. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
Kouri N; Carlomagno Y; Baker M; Liesinger AM; Caselli RJ; Wszolek ZK; Petrucelli L; Boeve BF; Parisi JE; Josephs KA; Uitti RJ; Ross OA; Graff-Radford NR; DeTure MA; Dickson DW; Rademakers R
Acta Neuropathol; 2014 Feb; 127(2):271-82. PubMed ID: 24121548
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers.
Wallon D; Boluda S; Rovelet-Lecrux A; Thierry M; Lagarde J; Miguel L; Lecourtois M; Bonnevalle A; Sarazin M; Bottlaender M; Mula M; Marty S; Nakamura N; Schramm C; Sellal F; Jonveaux T; Heitz C; Le Ber I; Epelbaum S; Magnin E; Zarea A; Rousseau S; Quenez O; Hannequin D; Clavaguera F; Campion D; Duyckaerts C; Nicolas G
Acta Neuropathol; 2021 Aug; 142(2):259-278. PubMed ID: 34095977
[TBL] [Abstract][Full Text] [Related]
15. Atypical globular glial tauopathy with a combination of types I and II pathology.
Kon T; Mori F; Arai A; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Wakabayashi K
Neuropathology; 2019 Apr; 39(2):127-134. PubMed ID: 30723950
[TBL] [Abstract][Full Text] [Related]
16. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
17. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
[TBL] [Abstract][Full Text] [Related]
18. Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia.
Hirano M; Iritani S; Fujishiro H; Torii Y; Kawashima K; Sekiguchi H; Habuchi C; Yamada K; Ikeda T; Hasegawa M; Ikeuchi T; Yoshida M; Ozaki N
Neuropathology; 2020 Oct; 40(5):515-525. PubMed ID: 33463808
[TBL] [Abstract][Full Text] [Related]
19. Globular glial tauopathy Type II: Clinicopathological study of two autopsy cases.
Tanaka H; Kawakatsu S; Toyoshima Y; Miura T; Mezaki N; Mano A; Sanpei K; Kobayashi R; Hayashi H; Otani K; Ikeuchi T; Onodera O; Kakita A; Takahashi H
Neuropathology; 2019 Apr; 39(2):111-119. PubMed ID: 30646429
[TBL] [Abstract][Full Text] [Related]
20. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
